Key Events This Week
30 Mar: Lower circuit hit amid heavy selling pressure (₹27.05)
1 Apr: Upper circuit hit on strong buying interest (₹28.05)
2 Apr: Marginal gain with subdued volume (₹29.06)
3 Apr: Week closes at ₹29.06, up 2.29% vs Sensex down 0.29%

Mangalam Drugs and Organics Ltd is Rated Strong Sell
2026-04-02 10:10:16Mangalam Drugs and Organics Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 May 2025. However, the analysis and financial metrics presented here reflect the company’s current position as of 02 April 2026, providing investors with an up-to-date view of its fundamentals, returns, and overall outlook.
Read full news article
Mangalam Drugs and Organics Ltd Locks at Upper Circuit With 5% Gain — Buyers Queue, Sellers Absent
2026-04-01 10:00:09At Rs 28.50, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Mangalam Drugs and Organics Ltd locked at its upper circuit of 5% on 1 Apr 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
Mangalam Drugs and Organics Ltd Locks at Lower Circuit With 4.92% Loss — Sellers Queue, No Buyers in Sight
2026-03-30 15:00:05At Rs 27.05, sellers were still queuing — but there were no buyers willing to take the other side. Mangalam Drugs and Organics Ltd locked at its lower circuit of 4.92% on 30 Mar 2026, with unfilled sell orders and a frozen price, reflecting persistent selling pressure in a micro-cap stock with limited liquidity.
Read full news articleMangalam Drugs Falls 4.60%: Circuit Hits and Volatility Define the Week
2026-03-28 17:05:19
Key Events This Week
23 Mar: Stock declines 1.41% amid broad market sell-off
24 Mar: Hits upper circuit at Rs.30.29, surging 4.16%
25 Mar: Recovers modestly, closing flat at Rs.29.36 (+1.14%)
27 Mar: Plunges to lower circuit, closing at Rs.28.41 (-3.24%)

Below All Moving Averages and Now at Lower Circuit: Mangalam Drugs and Organics Ltd Loses 3.9% in a Single Session
2026-03-27 13:00:04At Rs 28.43, sellers were still queuing — but there were no buyers willing to take the other side. Mangalam Drugs and Organics Ltd locked at its lower circuit of 5% on 27 Mar 2026, with unfilled sell orders and a frozen price, signalling persistent selling pressure in a micro-cap stock with limited liquidity.
Read full news article
Mangalam Drugs and Organics Ltd Locks at Upper Circuit With 4.16% Gain — Buyers Queue, Sellers Absent
2026-03-24 10:00:07At Rs 30.53, the buying was done — not because demand dried up, but because the exchange wouldn't let the stock go any higher. Mangalam Drugs and Organics Ltd locked at its upper circuit of 4.16% on 24 Mar 2026, with buyers queuing and no sellers willing to part with shares.
Read full news article
Mangalam Drugs and Organics Ltd Hits Lower Circuit Amid Heavy Selling Pressure
2026-03-19 13:00:05Shares of Mangalam Drugs and Organics Ltd plunged sharply on 19 Mar 2026, hitting the lower circuit limit as intense selling pressure gripped the stock. The pharmaceutical micro-cap witnessed a maximum daily loss of 4.77%, closing at ₹29.16, reflecting a significant investor sell-off amid deteriorating market sentiment and weak technical indicators.
Read full news articleCompliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
06-Apr-2026 | Source : BSESubmission of Compliance Certificate received from RTA under Regulation 74(5) of SEBI(DP) Regulations 2018
Announcement under Regulation 30 (LODR)-Change in Management
26-Mar-2026 | Source : BSEOutcome of Board meeting to accept the resignation tendered by Ms. Anuradha Pandey as Company Secretary & Compliance Officer(KMP) & Appointment of Ms. Shweta Patel as Company Secretary & Compliance Officer (KMP) of the Company.
Board Meeting Outcome for Outcome Of Board Meeting For Resignation Tendered By CS Anuradha Pandey Accepted By The Board Approval For The Appointment Of New Company Secretary Nominated By NRC Ms. Shweta Patel.
26-Mar-2026 | Source : BSEResignation tendered by CS Anuradha Pandey accepted by the Board approval for the appointment of New Company Secretary nominated by NRC Ms. Shweta Patel.
Corporate Actions
No Upcoming Board Meetings
Mangalam Drugs and Organics Ltd has declared 5% dividend, ex-date: 21 Dec 17
No Splits history available
No Bonus history available
No Rights history available







